Chennai, India

12th October 2019

Register Now

All PHUSE Single Day Events are FREE to members. To become a member click here. Registrations per company are limited to 20% of maximum attendance.



Faster Access to New Medicine – Cutting Down the Development Life Cycle by 25%: Is That a Dream or a Reality?



New advancements in the clinical world are leading to a drastic shift in the way drugs are developed. There has not just been a change in what research yields: the conduct and the efficiency of how research and development happen in today’s world has also seen progress. The number of years that would be spent in the lab a decade ago to identify one target out of many such molecules, and then further during its development right through to marketing, in comparison with global demand, needs review and thought as to how can we do this better. Sponsors are under tremendous pressure to meet the demands of the market and competition, trying to balance out the cost of development to ensure faster access to patients. With technology advancing into the age of artificial intelligence, faster and better solutions are available, yet we need to know how better to utilize them to our benefit.

So, what ideas do we have as a research industry to do better, faster and smarter? As contributors to the drug development organization, are we able to contribute to this need in our own way? How about efficient systems and tools to do data cleaning activities, or reducing the number of reports generated for an analysis? What can we each do to bring down cycle times and reruns of the same data repeatedly? Or is all this just a mere dream? Is it even close to becoming a reality? Let us debate, discuss and, together, decide on what we can do! The time to think is NOW!



Vivanta Chennai, IT Expressway
No 309 Rajiv Gandhi Salai (OMR), Sholinganallur,
Chennai 600119 Tamilnadu, India

Event Room: Concord 2



Time Presentation Speaker(s)
08.15–09.15 Registration and Welcome Refreshments
09.15–09.45 Welcome & PHUSE Updates Sarvesh Singh,
09.45–10.15 Going Digital in the Analysis & Reporting Space

Christopher J. Colangelo,

10.15–10.45 Accelerate Drug Development Using AI & ML

Anoop Ambika,

10.45–11.15 Seamless Adaptive Phase II/III Clinical Trials: An Example of Significant Reduction in Development of a Small Molecule Compound in Oncology (Time, Sample Size and Costs)

Tommy Pedersen,

11.15–11.30 Coffee Break
11.30–12.00 Evolution or Revolution? From Vision to Decision Pratibha Jalui,
12.00–12.30 A Stitch in Time Saves Nine – A Statistical Programmer's Perspective Jayapandian Nagamalaiyan,
12.30–1.00 Reducing the Clinical Drug Development Life Cycle Through a Smarter Decision-making Framework Driven by Statistical & Probabilistic Measures Sakthivel Sivam,
1.00–2.00 Lunch Break
2.00–2.30 Towards Automating Statistical Programming Ganesh Gopal,
2.30–3.00 Timeline Shift Vijayakumar Radhakrishnan,
3.00–3.30 RTOR – The Race is On Dipti Patil and Hemangini Gurlani,
3.30–3.45 Coffee Break
3.45–5.15 Panel Discussion and Q&A

Matt Ferdock, Navitas Life Sciences
Tommy Pederson, Cognizant
Patti Compton, Pfizer
Anoop Ambika, Genpro

5.15–5.30 Wrap-up & Closing Remarks Sarvesh Singh,


SDE Chairs:

Matt Ferdock, Navitas Life Sciences

Priya Iyer, Pfizer

If you have any questions, or require any information, please contact one of the SDE Chairs.






If you are interested in sponsoring this event, click here.


How Do I Join the PHUSE Society?

There are two easy ways to join PHUSE:

1. Register online.

2. Contact for group membership applications or for invoicing arrangements.


Thinking of joining PHUSE?

Already a member but not sure how you can benefit?

PHUSE is an expanding, global society with a global membership of clinical data scientists. It requires a large pool of resources to help with its running, and so there are many opportunities for members to become involved. Whether it's chairing a conference, presenting at an event, leading a working group or contributing to the quarterly online newsletter, we are always keen to hear from volunteers.

Find Out More